Literature DB >> 27410529

The pain drain.

David Holmes.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27410529     DOI： 10.1038/535S2a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

1.  Protein Kinase C Lambda Mediates Acid-Sensing Ion Channel 1a-Dependent Cortical Synaptic Plasticity and Pain Hypersensitivity.

Authors:  Hu-Song Li; Xin-Yu Su; Xing-Lei Song; Xin Qi; Ying Li; Rui-Qi Wang; Oleksandr Maximyuk; Oleg Krishtal; Tingting Wang; Houqin Fang; Lujian Liao; Hong Cao; Yu-Qiu Zhang; Michael X Zhu; Ming-Gang Liu; Tian-Le Xu
Journal:  J Neurosci       Date:  2019-05-17       Impact factor: 6.167

Review 2.  Long noncoding RNA (lncRNA): a target in neuropathic pain.

Authors:  Shaogen Wu; Jamie Bono; Yuan-Xiang Tao
Journal:  Expert Opin Ther Targets       Date:  2018-12-02       Impact factor: 6.902

3.  Pre-treatment with Meloxicam Prevents the Spinal Inflammation and Oxidative Stress in DRG Neurons that Accompany Painful Cervical Radiculopathy.

Authors:  Sonia Kartha; Christine L Weisshaar; Blythe H Philips; Beth A Winkelstein
Journal:  Neuroscience       Date:  2018-08-04       Impact factor: 3.590

4.  µ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects.

Authors:  Yun-Xiao Zhang; De-Zheng Peng; Qing-Feng Zhang; Biao Huang; Qiu-Chu Yang; Dong-Fang Tang; Min-Zhi Chen; Ming-Qiang Rong; Zhong-Hua Liu
Journal:  Acta Pharmacol Sin       Date:  2018-10-31       Impact factor: 6.150

Review 5.  The NaV1.7 Channel Subtype as an Antinociceptive Target for Spider Toxins in Adult Dorsal Root Ganglia Neurons.

Authors:  Tânia C Gonçalves; Evelyne Benoit; Michel Partiseti; Denis Servent
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

6.  Targeting nNOS ameliorates the severe neuropathic pain due to chronic pancreatitis.

Authors:  Ihsan Ekin Demir; Tobias Heinrich; Dominique G Carty; Ömer Cemil Saricaoglu; Sarah Klauss; Steffen Teller; Timo Kehl; Carmen Mota Reyes; Elke Tieftrunk; Maria Lazarou; Dorukhan H Bahceci; Betül Gökcek; Bahar E Ucurum; Matthias Maak; Kalliope N Diakopoulos; Marina Lesina; Michael Schemann; Mert Erkan; Achim Krüger; Hana Algül; Helmut Friess; Güralp O Ceyhan
Journal:  EBioMedicine       Date:  2019-08-08       Impact factor: 8.143

7.  Rat NaV1.7 loss-of-function genetic model: Deficient nociceptive and neuropathic pain behavior with retained olfactory function and intra-epidermal nerve fibers.

Authors:  B Grubinska; L Chen; M Alsaloum; N Rampal; D J Matson; C Yang; K Taborn; M Zhang; B Youngblood; D Liu; E Galbreath; S Allred; M Lepherd; R Ferrando; T J Kornecook; S G Lehto; S G Waxman; B D Moyer; S Dib-Hajj; J Gingras
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

8.  A neuroimaging marker for predicting longitudinal changes in pain intensity of subacute back pain based on large-scale brain network interactions.

Authors:  Bo-Yong Park; Jae-Joong Lee; Hong Ji Kim; Choong-Wan Woo; Hyunjin Park
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

Review 9.  Advances With Non-coding RNAs in Neuropathic Pain.

Authors:  Cheng Hu; Menglin He; Qian Xu; Weiqian Tian
Journal:  Front Neurosci       Date:  2021-12-23       Impact factor: 4.677

10.  Engineering Gain-of-Function Analogues of the Spider Venom Peptide HNTX-I, A Potent Blocker of the hNaV1.7 Sodium Channel.

Authors:  Yunxiao Zhang; Qiuchu Yang; Qingfeng Zhang; Dezheng Peng; Minzhi Chen; Songping Liang; Xi Zhou; Zhonghua Liu
Journal:  Toxins (Basel)       Date:  2018-09-04       Impact factor: 4.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.